Good morning, everyone, and thank you for joining us today. Earlier this morning, we issued a press release outlining the positive topline results from our SOL-1 Phase III clinical trial of AXPAXLI, ...
The decentralized finance landscape of 2026 is moving toward a massive shift. Investors are no longer looking for simple meme coins or empty promises. Instead, the market is rewarding projects that ...
First ever successful demonstration of superiority in an FDA-aligned wet AMD trial comparing a novel investigative agent to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results